NASDAQ · Financial Statements
Bellicum Pharmaceuticals, Inc. (BLCM) Financial Statements
$0.07
NASDAQ: BLCM
Market Cap $778326
Overview Financials Dividend Bellicum Pharmaceuticals, Inc. most recently reported annual revenue of $2.0M, net profit of $-25.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2018 2019 2020 2021 2022 Revenue $1.0M $7.0M $1.0M $6.0M $2.0M Operating Profit $-95.0M $-87.0M $-52.0M $-25.0M $-27.0M Net Profit $-98.0M $-126.0M $-9.0M $-10.0M $-25.0M EPS $-24.37 $-26.92 $-1.50 $-0.83 $-0.81 Op Margin -8523.8% -1223.1% -10338.4% -401.1% -1798.7%
Balance Sheet (USD)
Metric 2018 2019 2020 2021 2022 Total Assets $122.0M $116.0M $41.0M $49.0M $24.0M Total Liabilities $53.0M $142.0M $43.0M $25.0M $22.0M Cash $44.0M $91.0M $35.0M $46.0M $22.0M Borrowings $36.0M $38.0M $1.0M $0 $0
Cash Flow (USD)
Metric 2018 2019 2020 2021 2022 Operating Cash Flow $-75.0M $-78.0M $-57.0M $-23.0M $-26.0M Investing Cash Flow $9.0M $48.0M $13.0M $1.0M $0 Financing Cash Flow $68.0M $74.0M $-14.0M $33.0M $0 Net Cash Flow $4.0M $45.0M $-57.0M $11.0M $-26.0M Free Cash Flow $-76.0M $-78.0M $-57.0M $-23.0M $-26.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.84 FCF Yield -3315.32% Quick Ratio 6.31 Interest Coverage -586543.48 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock